PDCD1 and acute myeloid leukemia: Chen et al. analyzed The Cancer Genome Atlas (TCGA) database and verified 62 AML bone marrow samples and indicated that the combined high expression of PD1, PD-L1, PD-L2 and CTLA-4 was linked to reduce OS rates [43].